Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 27592 | 185 | 32.1 | 34% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 460 | 15323 | EDUCATIONAL ADMINISTRATION QUARTERLY//SCHOOL EFFECTIVENESS AND SCHOOL IMPROVEMENT//EDUCATIONAL EVALUATION AND POLICY ANALYSIS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | REGRESSION DISCONTINUITY DESIGNS | Author keyword | 6 | 80% | 2% | 4 |
| 2 | REGRESSION DISCONTINUITY | Author keyword | 4 | 16% | 12% | 22 |
| 3 | BIASED ALLOCATION | Author keyword | 2 | 67% | 1% | 2 |
| 4 | REGRESSION DISCONTINUITY DESIGN | Author keyword | 2 | 17% | 5% | 10 |
| 5 | DEMOCRATIZATION OF EDUCATION | Author keyword | 1 | 100% | 1% | 2 |
| 6 | EXIT EXAMINATIONS | Author keyword | 1 | 40% | 1% | 2 |
| 7 | CONDITIONAL MLE | Author keyword | 1 | 50% | 1% | 1 |
| 8 | INFORMATION TREATMENTS | Author keyword | 1 | 50% | 1% | 1 |
| 9 | LEEDS CLIN TRIALS UNIT | Address | 1 | 50% | 1% | 1 |
| 10 | LITTAUER M 24 | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RANDOM MEASUREMENT ERROR | 3 | 57% | 2% | 4 |
| 2 | REGRESSION DISCONTINUITY DESIGN | 2 | 11% | 7% | 13 |
| 3 | SCHOOL EXIT EXAM | 1 | 100% | 1% | 2 |
| 4 | REGRESSION DISCONTINUITY DESIGNS | 1 | 11% | 5% | 10 |
| 5 | PROPHYLACTIC TRIALS | 1 | 20% | 3% | 5 |
| 6 | GREATER RISK | 1 | 14% | 3% | 5 |
| 7 | EQUIPERCENTILE | 1 | 50% | 1% | 1 |
| 8 | RULE LEAST SQUARES | 1 | 50% | 1% | 1 |
| 9 | TITLE I | 1 | 16% | 2% | 3 |
| 10 | INCIDENT AIDS | 0 | 33% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice | 2015 | 0 | 43 | 30% |
| Agroecological practices for sustainable agriculture. A review | 2014 | 11 | 99 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LEEDS CLIN TRIALS UNIT | 1 | 50% | 0.5% | 1 |
| 2 | LITTAUER M 24 | 1 | 50% | 0.5% | 1 |
| 3 | 4C | 0 | 33% | 0.5% | 1 |
| 4 | FED ERVE BANK DALLAS | 0 | 33% | 0.5% | 1 |
| 5 | COMPETIT ADV GLOBAL ECON CAGE | 0 | 25% | 0.5% | 1 |
| 6 | CRIME LAW JUSTICE SOCIOL | 0 | 25% | 0.5% | 1 |
| 7 | GERALD FORD PUBL POLICY | 0 | 20% | 0.5% | 1 |
| 8 | MICROECON REG STUDIES FUNCT | 0 | 20% | 0.5% | 1 |
| 9 | STOCKHOLM TRANSIT ECON | 0 | 20% | 0.5% | 1 |
| 10 | POLICY INT STUDIES | 0 | 11% | 1.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000177468 | PROPENSITY SCORE//MATCHED SAMPLING//UNCONFOUNDEDNESS |
| 2 | 0.0000150568 | GRADE RETENTION//EARLY SCHOOL LEAVING//KINDERGARTEN ENTRY AGE |
| 3 | 0.0000148503 | PEER EFFECTS//ECONOMICS OF EDUCATION REVIEW//EDUCATION PRODUCTION FUNCTION |
| 4 | 0.0000136680 | SUMMER LEARNING//SUMMER LEARNING LOSS//YEAR ROUND SCHOOLS |
| 5 | 0.0000130321 | EURYTHMY THERAPY//REGRESSION TO THE MEAN//ANTHROPOSOPHIC PSYCHOTHERAPY |
| 6 | 0.0000113345 | FINANCIAL AID//RESEARCH IN HIGHER EDUCATION//STUDENT FINANCIAL AID |
| 7 | 0.0000084691 | ARQUIVOS BRASILEROS DE PSICOLOGIA//CLIENT PROFILE//PSYCHOLOGICAL SERVICE |
| 8 | 0.0000084019 | INTERGENERATIONAL MOBILITY//INTERGENERATIONAL INCOME MOBILITY//INCOME GRADIENT |
| 9 | 0.0000076265 | ENTERPRISE ZONES//EMPOWERMENT ZONES//TAX INCREMENT FINANCING |
| 10 | 0.0000066243 | COOPERATIVE ONCOLOGY GROUPS//GLOBAL HIV VACCINE ENTERPRISE//SCIENTIFIC ENTERPRISE |